LamassuBiotech
  • Company
    • Mission & History
    • Leadership & Key Collaborators
    • Partners
  • The Lamassu Method
  • Pipeline
    • SA53
    • RABI-767
  • Lamassu Pets
  • Investor Resources
    • Investor Resources
    • Events & Presentations
  • News
    • News Releases
    • Media Coverage
  • Contact Us
  • EN
  • FR

Tag: Media

11/05/2024

Cleveland.com: Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

CLEVELAND, Ohio — A biotech startup from North Carolina thinks Cleveland is where it will develop how to treat rare cancers with just three pills a month. If effective, Lamassu Biotech’s innovative...
READ THE ARTICLE
06/14/2024

Pharma Exec: Lamassu Pharma Bridges Scientific Knowledge and Patient Care

In the realm of drug development, the industry puts a great deal of emphasis on centering the patient experience. As a result, it is imperative that drug developers consider how...
READ THE ARTICLE
05/21/2024

Crain’s Cleveland Business: Lamassu Biotech expanding corporate offices to Cleveland

A North Carolina biotech research firm is expanding its novel therapeutic and drug development efforts to Cleveland. Lamassu Biotech said it's launching corporate offices in the city. The company is...
READ THE ARTICLE

Posts navigation

Newer posts

Recent Posts

  • Crain’s Cleveland Business: The U.S. Is Losing Its Biotech Edge
  • Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding
  • Cleveland Business Journal: Lamassu Biotech’s dog treatment could lead to human pancreatitis breakthrough, backed by NIH funds
  • SIGNIFICANT NIH GRANT WILL HELP LAMASSU BIOTECH ADVANCE LIFE-SAVING PANCREATITIS TREATMENT FOR DOGS
  • LAMASSU BIOTECH COLLABORATES WITH THE OHIO STATE UNIVERSITY TO STUDY NEW THERAPY FOR MAN AND MAN’S BEST FRIEND

Recent Comments

No comments to show.

Archives

  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • April 2021
  • August 2020
  • March 2020

Categories

  • media
  • news
  • Uncategorized

Menu

  • Investor Resources
  • News Releases
  • Contact us

Questions?

1-919-246-3969

info@lamassubio.com

  • Privacy Statement
  • Terms Of Use
  • Accessibility
  • FCOI Policies